Jim Cramer
GE Healthcare soars 9% on earnings beat, wise guidance. Here’s our new price target
Things continue to look up for GE Healthcare stock this year. Shares of the medical technology company jumped roughly 9% on Thursday after delivering solid fourth-quarter results and providing prudent 2025 guidance. While the Club stock left much to be desired in 2024, these numbers boosted shares that were already bouncing off their most recent […]
Read More
We’re adding to our position in a sliding stock and booking profits in a 2025 winner
We’re making a pair of trades Monday as Wall Street rallies to kick off the week. Source
Read More
Bristol Myers’ stock decline in response to weak guidance is a gift to investors
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts’ estimates compiled by LSEG. Adjusted earnings per […]
Read More
Columbia Sportswear CEO talks tariff impact: ‘We need some surety about what’s going to happen’
In a Wednesday interview with CNBC’s Jim Cramer, Columbia Sportswear CEO Tim Boyle said his company needs more clarity about global tariff decisions in order to plan for what’s to come. “It’s a dampening effect,” he said. “But, more importantly, we need some surety about what is going to happen, what’s the future.” President Donald […]
Read More
We’re making 4 trades, including an exit and an initiation, to reduce our tariff risk
Looking to reduce our exposure to tariffs and China, we’re making changes in the portfolio. We’re exiting our position in Stanley Black & Decker , selling our remaining 510 shares at roughly $86.79 each. We’re buying 50 shares of Home Depot at roughly $409.60. Following the trade, Jim Cramer’s Charitable Trust will own 300 shares […]
Read More
Flexport CEO breaks down the complex and uncertain global trade landscape
As the market reels from ever-changing news about President Donald Trump’s tariff hikes, Flexport CEO Ryan Petersen detailed how his customers are dealing with a volatile global trade environment in a Monday interview with CNBC’s Jim Cramer. “It’s very hard to plan a supply chain when it’s changing day to day, so I think it’s […]
Read More
Some of this week’s biggest stock winners and losers, plus an update on Nvidia
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update: Stocks moved off their session highs and struggled to hold onto their gains. The S & P 500 is on pace for a small […]
Read More
We’re cutting our price target on Danaher as frustration mounts after a messy quarter
Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience. Revenue for the three months ended Dec. 31 advanced 2% year over year on a reported basis, to $6.54 billion, outpacing the LSEG […]
Read More
We’re lightening up on a rallying stock that’s grown too big in our portfolio
The sale also comes as our trusted momentum indicator moved further into overbought territory. Source
Read More
We’re trimming a 2025 top gainer, taking profits on the market’s rotation into health stocks
We are selling 75 shares of GE Healthcare at roughly $90 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of GEHC, decreasing its weighting to about 2.25% from 2.42%. We’re taking advantage of the market’s rotation into health-care stocks by locking in profits in GE Healthcare. Following an up-and-down 2024, GE […]
Read More